Impact of respiratory pathogens detection by a rapid multiplex polymerase chain reaction assay on the management of community-acquired pneumonia for children at the paediatric emergency department. A randomized controlled trial, the Optimization of Pneumonia Acute Care (OPTIPAC) study.

Détails

ID Serval
serval:BIB_8B8C4FF28937
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Impact of respiratory pathogens detection by a rapid multiplex polymerase chain reaction assay on the management of community-acquired pneumonia for children at the paediatric emergency department. A randomized controlled trial, the Optimization of Pneumonia Acute Care (OPTIPAC) study.
Périodique
Clinical microbiology and infection
Auteur⸱e⸱s
Cantais A., Pillet S., Rigaill J., Angoulvant F., Gras-Le-Guen C., Cros P., Thuiller C., Molly C., Tripodi L., Desbree A., Annino N., Verhoeven P., Carricajo A., Bourlet T., Chapelle C., Claudet I., Garcin A., Izopet J., Mory O., Pozzetto B.
Collaborateur⸱rice⸱s
OPTIPAC study group
ISSN
1469-0691 (Electronic)
ISSN-L
1198-743X
Statut éditorial
Publié
Date de publication
05/08/2024
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: aheadofprint
Résumé
The pathogen of community-acquired pneumonia (CAP) in children is typically uncertain during initial treatment, leading to systematic empiric antibiotic use. This study investigates if having rapid multiplex PCR results in the emergency department (ED) improves empiric treatment.
OPTIPAC, a French multicentre study (2016-2018), enrolled patients consulting for CAP at the paediatric ED in 11 centres. Patients were randomized to either receive a multiplex PCR test plus usual care or usual care alone and followed for 15 days. The primary outcome was the appropriateness of initial antimicrobial management, determined by a blinded committee.
Of the 499 randomized patients, 248 were tested with the multiplex PCR. Appropriateness of the antibiotic treatment was higher in the PCR group (168/245, 68.6% vs. 120/249, 48.2%; Relative risk 1.42 [1.22-1.66]; p < 0.0001), chiefly by reducing unnecessary antibiotics in viral pneumonia (RR 3.29 [2.20-4.90]). No adverse events were identified.
The multiplex PCR assay result at the ED improves paediatric CAP's antimicrobial stewardship, by both reducing antibiotic prescriptions and enhancing treatment appropriateness.
Mots-clé
Antibiotic stewardship, Emergency, PCR multiplex, Paediatric, Pneumonia
Pubmed
Création de la notice
04/11/2024 14:28
Dernière modification de la notice
05/11/2024 7:14
Données d'usage